COVID-19

COVID-19 INFO #3: Data Collection and More

April 7, 2020 | AplusA

As the COVID-19 situation develops and as AplusA teams have been receiving questions regarding the impact of COVID-19 on market research activity. We are posting this info series in order to keep...

Read More

COVID-19

COVID-19 INFO #2: HCP Respondent Response

March 30, 2020 | AplusA

As the COVID-19 situation develops we want to keep our clients and community updated on the impact on our industry. Here are the latest updates from AplusA as of March 27, 2020.

Read More

COVID-19

Coronavirus: The Evolution of its Many Names

March 27, 2020 | AplusA

AplusA utilized social media analysis tools to observe the evolution of the use of the different names for coronavirus.

Read More

COVID-19

COVID-19 INFO #1: Data Collection

March 23, 2020 | AplusA

AplusA teams have been receiving questions regarding the impact of COVID-19 on market research activity. Below is an overview of the situation as of March 20, 2020. 

Read More

COVID-19 Message of Thanks to AplusA Healthcare Professional Study Participants

March 19, 2020 | AplusA

Doctor Christine Maï, AplusA Executive Vice-President, sent the following message to the healthcare professional study participants on March 19 2020.

Read More

AplusA COVID-19 Business Continuity Plan

March 16, 2020 | AplusA

In light of the current global COVID-19 outbreak, we wanted to share key points from AplusA's Business Continuity Plan designed to minimize the impact of the current situation on employee health...

Read More

Products and Services Healthcare Industry Market Research Industry Digital

DLBCL Case Study: Enhancing Patient Journey Research with Social Media Listening

November 13, 2019 | AplusA

Using the example of a recent AplusA study in Diffuse Large B-Cell Lymphoma (DLBCL), we consider combining the emotional, behavioural, and clinical dimensions of the patient journey using...

Read More

hemato-oncology

Patient Insights from AplusA’s Multiple Myeloma Tracker

October 30, 2019 | AplusA

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the results of a syndicated AplusA tracking study on the multiple myeloma market, this series of blog...

Read More

hemato-oncology

Multiple Myeloma Market Dynamics Revealed by AplusA Tracker

October 30, 2019 | AplusA

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the results of a syndicated AplusA tracking study on the multiple myeloma market, this series of blog...

Read More

hemato-oncology

Brand Performance Insights from AplusA's Multiple Myeloma Tracker

October 28, 2019 | AplusA

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the results of a syndicated AplusA tracking study on the multiple myeloma market, this series of blog...

Read More